IM Cannabis (IMCC) Retained Earnings (2019 - 2026)
IM Cannabis (IMCC) recorded quarterly Retained Earnings of -$198.6 million in Q1 2026, down 2.51% quarter-over-quarter from -$193.8 million in Q4 2025, and down 10.2% on a YoY basis from -$221.2 million in Q1 2025.
IM Cannabis (IMCC) Retained Earnings (2019 - 2026) Analysis & Trends
IM Cannabis' Retained Earnings history runs 8 years deep, the most recent figure standing at -$198.6 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 10.2% year-over-year to -$198.6 million; the TTM figure through Mar 2026 stood at -$198.6 million (down 10.2% YoY), while the FY2025 annual figure was -$193.8 million, down 2.45% from the prior year.
- Retained Earnings was -$198.6 million for Q1 2026 at IM Cannabis, down from -$193.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$47.5 million in Q1 2022 to a low of -$198.6 million in Q1 2026.
- Historically, Retained Earnings has averaged -$169.0 million across 5 years, with a median of -$183.3 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 338.43% in 2022, then grew 4.91% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$176.5 million in 2022, then fell by 3.69% to -$183.0 million in 2023, then slipped by 1.29% to -$185.4 million in 2024, then slipped by 4.53% to -$193.8 million in 2025, then dropped by 2.51% to -$198.6 million in 2026.
- The last three Retained Earnings figures came in at -$198.6 million (Q1 2026), -$193.8 million (Q4 2025), and -$190.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | -198.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -198.62 Mn |
| Dec 31, 2025 | -193.76 Mn |
| Sep 30, 2025 | -190.80 Mn |
| Jun 30, 2025 | -186.87 Mn |
| Mar 31, 2025 | -180.24 Mn |
| Dec 31, 2024 | -185.36 Mn |
| Sep 30, 2024 | -190.15 Mn |
| Jun 30, 2024 | -188.98 Mn |
| Mar 31, 2024 | -189.56 Mn |
| Dec 31, 2023 | -183.01 Mn |
| Sep 30, 2023 | -183.31 Mn |
| Jun 30, 2023 | -181.35 Mn |
| Mar 31, 2023 | -176.96 Mn |
| Dec 31, 2022 | -176.49 Mn |
| Sep 30, 2022 | -158.41 Mn |
| Jun 30, 2022 | -61.85 Mn |
| Mar 31, 2022 | -47.52 Mn |
| Dec 31, 2021 | -40.26 Mn |
| Dec 31, 2020 | -25.31 Mn |
| Dec 31, 2019 | -3.24 Mn |